Berenberg Bank Reiterates Buy Rating for Diploma (LON:DPLM)

Diploma (LON:DPLMGet Free Report)‘s stock had its “buy” rating reissued by analysts at Berenberg Bank in a research report issued on Monday, Marketbeat.com reports. They presently have a GBX 9,000 price target on the stock. Berenberg Bank’s price objective indicates a potential upside of 20.48% from the company’s previous close.

A number of other research analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft upped their price target on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the company a “buy” rating in a research note on Wednesday, May 20th. Royal Bank Of Canada boosted their price objective on Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a report on Friday, July 17th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 7,000 target price on shares of Diploma in a research report on Friday, May 29th. Finally, JPMorgan Chase & Co. increased their target price on Diploma from GBX 5,120 to GBX 5,760 and gave the stock a “neutral” rating in a research note on Friday, March 27th. Five investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of GBX 7,044.29.

Check Out Our Latest Report on DPLM

Diploma Price Performance

LON:DPLM opened at GBX 7,470 on Monday. The company has a market cap of £10.02 billion, a P/E ratio of 53.05, a P/E/G ratio of 2.82 and a beta of 0.92. The firm’s fifty day moving average price is GBX 6,995.25 and its two-hundred day moving average price is GBX 6,273.01. Diploma has a one year low of GBX 4,970 and a one year high of GBX 7,663.22. The company has a debt-to-equity ratio of 47.65, a current ratio of 2.06 and a quick ratio of 0.80.

Diploma (LON:DPLMGet Free Report) last posted its earnings results on Tuesday, May 19th. The company reported GBX 74.70 earnings per share (EPS) for the quarter. The company had revenue of £851.10 million during the quarter. Diploma had a net margin of 9.42% and a return on equity of 18.55%. Equities analysts expect that Diploma will post 163.7995512 earnings per share for the current year.

Insider Buying and Selling

In other Diploma news, insider Mandy Gradden acquired 1,000 shares of the company’s stock in a transaction on Friday, July 17th. The stock was acquired at an average price of GBX 7,183 per share, for a total transaction of £71,830. Also, insider Katie Bickerstaffe  acquired 177 shares of the business’s stock in a transaction on Wednesday, May 20th. The stock was acquired at an average cost of GBX 6,730 per share, with a total value of £11,912.10. Over the last three months, insiders have acquired 1,781 shares of company stock valued at $12,638,928. 1.14% of the stock is owned by company insiders.

Diploma News Roundup

Here are the key news stories impacting Diploma this week:

  • Positive Sentiment: Berenberg Bank reiterated its buy rating on Diploma PLC and raised its price target to GBX 9,000, suggesting analysts still see meaningful upside from current levels. Broker views source
  • Positive Sentiment: Multiple senior insiders purchased shares, including Mandy Gradden, Wilson Ng, and Katie Bickerstaffe. Insider buying is often viewed as a vote of confidence in the company’s outlook and valuation. TipRanks article
  • Neutral Sentiment: A MarketWatch note said Diploma outperformed the broader market on Monday, but it did not point to a new company-specific fundamental development. MarketWatch article

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Further Reading

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.